418 related articles for article (PubMed ID: 15578005)
1. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol.
Mo YQ; Jin XL; Chen YT; Jin GZ; Shi WX
Neuropsychopharmacology; 2005 Feb; 30(2):261-7. PubMed ID: 15578005
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization of neuroleptic-sensitive neurons in the forebrain: contrasting targets of haloperidol and clozapine.
Guo N; Vincent SR; Fibiger HC
Neuropsychopharmacology; 1998 Aug; 19(2):133-45. PubMed ID: 9629567
[TBL] [Abstract][Full Text] [Related]
3. Involvement of dopamine D1 and D2 receptors in Fos immunoreactivity induced by stepholidine in both intact and denervated striatum of lesioned rats.
Guo X; Ding YM; Hu JY; Jin GZ
Life Sci; 1998; 62(25):2295-302. PubMed ID: 9651118
[TBL] [Abstract][Full Text] [Related]
4. c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.
Zhao C; Li M
Neuroscience; 2010 Apr; 166(4):1043-55. PubMed ID: 20096751
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
Robertson GS; Fibiger HC
Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
[TBL] [Abstract][Full Text] [Related]
6. L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.
Lee J; Rushlow WJ; Rajakumar N
Neuroscience; 2007 Nov; 149(3):602-16. PubMed ID: 17913375
[TBL] [Abstract][Full Text] [Related]
7. Effects of YM-43611, a novel dopamine D2-like receptor antagonist, on immediate early gene expression in the rat forebrain.
Kurokawa K; Narita M; Koshiya K; Hidaka K; Ohmori J; Satoh K
Neuropsychopharmacology; 1997 Jul; 17(1):27-33. PubMed ID: 9194047
[TBL] [Abstract][Full Text] [Related]
8. Effects of perospirone, a novel 5-HT2 and D2 receptor antagonist, on Fos protein expression in the rat forebrain.
Ishibashi T; Tagashira R; Nakamura M; Noguchi H; Ohno Y
Pharmacol Biochem Behav; 1999 Aug; 63(4):535-41. PubMed ID: 10462181
[TBL] [Abstract][Full Text] [Related]
9. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain.
Wan W; Ennulat DJ; Cohen BM
Brain Res; 1995 Aug; 688(1-2):95-104. PubMed ID: 8542328
[TBL] [Abstract][Full Text] [Related]
10. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization.
Deutch AY; Duman RS
Neuroscience; 1996 Jan; 70(2):377-89. PubMed ID: 8848147
[TBL] [Abstract][Full Text] [Related]
11. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
12. Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors.
Merchant KM; Figur LM; Evans DL
Cereb Cortex; 1996; 6(4):561-70. PubMed ID: 8670682
[TBL] [Abstract][Full Text] [Related]
13. I-stepholidine facilitates inhibition of mPFC DA receptors on subcortical NAc DA release.
Zhu ZT; Wu WR; Fu Y; Jin GZ
Acta Pharmacol Sin; 2000 Jul; 21(7):663-7. PubMed ID: 11360679
[TBL] [Abstract][Full Text] [Related]
14. Effects of (-)stepholidine in animal models for schizophrenia.
Ellenbroek BA; Zhang XX; Jin GZ
Acta Pharmacol Sin; 2006 Sep; 27(9):1111-8. PubMed ID: 16923330
[TBL] [Abstract][Full Text] [Related]
15. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
16. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine.
Werme M; Ringholm A; Olson L; Brené S
Brain Res; 2000 Apr; 863(1-2):112-9. PubMed ID: 10773199
[TBL] [Abstract][Full Text] [Related]
17. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity.
Robertson GS; Matsumura H; Fibiger HC
J Pharmacol Exp Ther; 1994 Nov; 271(2):1058-66. PubMed ID: 7965768
[TBL] [Abstract][Full Text] [Related]
18. Comparison of (-)-stepholidine and D1 or D2 agonists on unit firing of globus pallidus in 6-hydroxydopamine-lesioned rats.
Zhang XX; Zhu ZT; Jin GZ
Life Sci; 1998; 63(7):537-44. PubMed ID: 9718079
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 10A inhibitor, MP-10 (PF-2545920), produces greater induction of c-Fos in dopamine D2 neurons than in D1 neurons in the neostriatum.
Wilson JM; Ogden AM; Loomis S; Gilmour G; Baucum AJ; Belecky-Adams TL; Merchant KM
Neuropharmacology; 2015 Dec; 99():379-86. PubMed ID: 26256420
[TBL] [Abstract][Full Text] [Related]
20. L-Stepholidine, a naturally occurring dopamine D1 receptor agonist and D2 receptor antagonist, attenuates heroin self-administration and cue-induced reinstatement in rats.
Yue K; Ma B; Chen L; Tian X; Ru Q; Gan Y; Wang D; Jin G; Li C
Neuroreport; 2014 Jan; 25(1):7-11. PubMed ID: 24145772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
